Cargando…

Relapse recovery: The forgotten variable in multiple sclerosis clinical trials

OBJECTIVE: To determine whether basing the decision to initiate immediate vs delayed disease-modifying therapy (DMT) on extent of recovery after initial relapse affects long-term disability accumulation in a multiple sclerosis (MS) evidence-based setting. METHODS: We analyzed the double-blind, place...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kantarci, Orhun H., Zeydan, Burcu, Atkinson, Elizabeth J., Conway, Brittani L., Castrillo-Viguera, Carmen, Rodriguez, Moses
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943367/ https://www.ncbi.nlm.nih.gov/pubmed/31848231 http://dx.doi.org/10.1212/NXI.0000000000000653

Ejemplares similares

Do magnetic resonance imaging features differ between persons with multiple sclerosis of various races and ethnicities?
por: Nathoo, Nabeela, et al.
Publicado: (2023)

Reproductive history and progressive multiple sclerosis risk in women
por: Zeydan, Burcu, et al.
Publicado: (2020)

A new dawn for genetic association studies in multiple sclerosis
por: Kantarci, Orhun H.
Publicado: (2016)

Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
por: Zeydan, Burcu, et al.
Publicado: (2020)

Addressing the targeting range of the ABILHAND-56 in relapsing–remitting multiple sclerosis: A mixed methods psychometric study
por: Cleanthous, Sophie, et al.
Publicado: (2018)

Infliximab is a plausible alternative for neurologic complications of Behçet disease
por: Zeydan, Burcu, et al.
Publicado: (2016)

Cervical spinal cord atrophy: An early marker of progressive MS onset
por: Zeydan, Burcu, et al.
Publicado: (2018)

Erythrocytes in multiple sclerosis – forgotten contributors to the pathophysiology?
por: Groen, Kira, et al.
Publicado: (2016)

Relapse recovery in relapsing–remitting multiple sclerosis: An analysis of the CombiRx dataset
por: Koch, Marcus W, et al.
Publicado: (2023)

Multiple Sclerosis Susceptibility Genes: Associations with Relapse Severity and Recovery
por: Mowry, Ellen M., et al.
Publicado: (2013)

Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered
por: Rahn, Kristen, et al.
Publicado: (2012)

Forgotten Variables and Incarcerated Males
por: Randall, George, et al.
Publicado: (2020)

The Forgotten Brother: The Innate-like B1 Cell in Multiple Sclerosis
por: Halperin, Saar T., et al.
Publicado: (2022)

Recovery after spinal cord relapse in multiple sclerosis is predicted by radial diffusivity
por: Freund, Patrick, et al.
Publicado: (2010)

Improvement in relapse recovery with peginterferon beta-1a in patients with multiple sclerosis
por: Scott, Thomas F, et al.
Publicado: (2016)

Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability
por: Sotiropoulos, Marinos G, et al.
Publicado: (2021)

Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients
por: Nabavi, Seyed Massood, et al.
Publicado: (2015)

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
por: Chen, Jun, et al.
Publicado: (2016)

Peginterferon beta-1a reduces the evolution of MRI lesions to black holes in patients with RRMS: a post hoc analysis from the ADVANCE study
por: Arnold, Douglas L., et al.
Publicado: (2017)

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
por: Coret, Francisco, et al.
Publicado: (2018)

Development of a gait module to complement the 12-item Multiple Sclerosis Walking Scale: a mixed methods study
por: Strzok, Sara, et al.
Publicado: (2018)

Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse
por: Mills, Elizabeth A., et al.
Publicado: (2017)

Recovery from an acute relapse is associated with changes in motor resting-state connectivity in multiple sclerosis
por: Dogonowski, Anne-Marie, et al.
Publicado: (2016)

Forgotten Variables in Gerontological Evaluation of Religiosity and Spirituality
por: Bishop, Alex, et al.
Publicado: (2020)

Forgotten Variables in Gerontological Evaluation of Religiosity and Spirituality
por: Firdausya, Nadia, et al.
Publicado: (2020)

Natalizumab for the treatment of relapsing multiple sclerosis
por: Rudick, Richard A, et al.
Publicado: (2008)

Seasonal variation in multiple sclerosis relapse
por: Harding, Katharine, et al.
Publicado: (2017)

Factors Involved in Relapse of Multiple Sclerosis
por: Kamel, Fatemah Omar
Publicado: (2019)

Osteopontin Is Associated with Multiple Sclerosis Relapses
por: Stampanoni Bassi, Mario, et al.
Publicado: (2023)

Enteroviral Infection: The Forgotten Link to Amyotrophic Lateral Sclerosis?
por: Xue, Yuan Chao, et al.
Publicado: (2018)

Antibody characterization using immunosignatures
por: Stafford, Phillip, et al.
Publicado: (2020)

Investigation of white matter PiB uptake as a marker of white matter integrity
por: Zeydan, Burcu, et al.
Publicado: (2019)

Development of Cortical Lesion Volumes on Double Inversion Recovery MRI in Patients With Relapse-Onset Multiple Sclerosis
por: Faizy, Tobias D., et al.
Publicado: (2019)

Distinctive Pattern of Cognitive Disorders During Multiple Sclerosis Relapse and Recovery Based on Computerized CANTAB Tests
por: Giedraitiene, Natasa, et al.
Publicado: (2019)

Hypoxemia and hypertension in obstructive sleep apnea: the forgotten variable
por: Borsini, Eduardo, et al.
Publicado: (2023)

Multiple Sclerosis: Basic Concepts and Hypothesis
por: RODRIGUEZ, MOSES
Publicado: (1989)

Evidence of Autonomic Dysfunction in Patients with Relapsing-Remitting Multiple Sclerosis: Heart Rate Variability and Cardiovascular Parameters
por: Gerasimova-Meigal, Liudmila, et al.
Publicado: (2021)

Hopelessness in Patients with Early-Stage Relapsing-Remitting Multiple Sclerosis
por: Sainz de la Maza, Susana, et al.
Publicado: (2023)

Jacksonian seizure as the relapse symptom of multiple sclerosis
por: Najafi, Mohammad Reza, et al.
Publicado: (2013)

Lymphopenia in treatment-naive relapsing multiple sclerosis
por: Lim, Zhi Wei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8uorncv0tfhuncphh6quvur0k2